Sensitization of The Antibiotic Resistant M. smegmatis Bacteria Using CRISPR/FnCpf1 Gene Editing, 1-13

The Effect Of Beta-Lactam-Containing Drugs On The Development Of Drug Allergy, 14-24

Making Antibiotic-Resistant E. coli Non-Resistant with CRISPR/Cas9 Gene Editing, 25-30

Chaperonin Variants in The Genus Acetobacter impacts Resistance To The Heat-Shock Stress, 31-27

Fanzor: A Promising CRISPR-like Gene Editing Tool in Eukaryotes, 38-42



Gene editing tools and the treatment of cystic fibrosis disease, 1-8

Gene Therapy Products Approved in 2022, 9-13

The CRISPR-Cas12 SHERLOCK System Can Identify HIV, 14-18

Development of DNA Ink & DNA Barcoding Technology on Practical Tracking & Authenticity Detection of Pharmaceutical Ingredients, 19-29

Expression of Axolotl P53 Gene May Increase Cancer Resistance, 30-34



Gene Therapy Products Reached to Market by 2021, 1-21

Development of Gene Editing Strategies for CCR5 Gene in Endothelial Cells, 22-30

Diagnosis and Treatment of Fanconi Anemia: Special Focus on Nuclease-Mediated Gene Therapy, 31-35

The Development of Recombinant hSpCas9 Production System in E. coli, 36-43

Development of CXCR4 Gene Editing in Human Umbilical Vein Endothelial Cells Using the CRISPR/CAS9 System, 44-49

The Effect Of Molecular Genetic Mechanisms On Drug Addiction And Related New Generation CRISPR Gene Engineering Applications, 50-60



The use of CRISPR/Cas9 gene editing system in the treatment of HBV infection, 1-7  

Gene editing studies for the treatment of AIDS, 8-20

Gene editing studies for the treatment of anemia, 21-29

Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobials, 30-35